).
Purpose:
To investigate the association between preoperative breast magnetic resonance (MR) imaging and surgical outcomes in patients with invasive lobular carcinoma (ILC) by using propensity score matching to decide whether MR examination is beneficial in the ILC subtype of breast cancer.
Materials and Methods:
The authors identified 603 patients with ILC who underwent surgery between January 2005 and December 2016. Of the 603 patients, 369 (61.2%) underwent MR imaging. The authors calculated the MR detection rate of additional lesions that were occult at mammography and ultrasonography and analyzed any alterations in surgical management. After propensity score matching, 196 pairs of patients were allocated to the groups, and the 17 possible confounding variables regarding patient and tumor characteristics and various clinical features were well balanced between the patients who underwent MR imaging and those who did not. Surgical outcomes were compared.
Results:
Of the 369 patients who underwent MR imaging, additional lesions were detected in 145 (39.3%); 95 of the 145 patients (65.5%) had malignant lesions. A change in surgical management occurred because of MR findings in 94 of the 369 patients (25.5%). According to pathologic findings, this change was appropriate for 84 of the 94 patients (89.4%). In the propensity score-matched analysis, breast MR imaging was associated with lower odds of repeat surgery (odds ratio, 0.140; P , .001) and similar likelihood of initial mastectomy (odds ratio, 0.876; P = .528) and final mastectomy (odds ratio, 0.744; P = .151) compared with patients without breast MR imaging.
Conclusion:
Preoperative MR imaging is useful for detecting additional synchronous malignancy and significantly reducing the likelihood of repeat surgery without increasing the rate of mastectomy in patients with ILC.
BREAST IMAGING: Breast MR Imaging before Surgery Ha et al
MR Imaging Technique
Patients underwent dynamic contrast material-enhanced MR imaging with either a 1.5-or 3.0-T imager (MagnetomAvanto or Skyra, Siemens Medical Solutions, Erlangen, Germany; Achieva, Philips Medical Systems, Best, the Netherlands) and a dedicated 18-channel phased-array breast coil. Imaging protocols included a T2-weighted sequence and a dynamic contrast-enhanced fatsuppressed axial three-dimensional T1-weighted sequence that consisted of an unenhanced acquisition and at least three contrast-enhanced acquisitions.
For axial T2-weighted imaging, a fast spin-echo sequence with fat suppression was used (1.5 T: repetition time msec/echo time msec = 6700/74, field of view = 300 3 300 mm, matrix size = 448 3 448, and section thickness = 5 mm; 3.0 T: 1100/131, field of view = 341 3 210 mm 2 ; matrix size = 256 3 416, and section thickness = 1.5 mm).
Dynamic contrast-enhanced images were obtained with fast low-angle shot volume-interpolated breath-hold examination pulse sequences (1.5 T: 5.2/2.4, field of view = 340 3 340 mm, matrix size = 384 3 384, section thickness = 0.9 mm; 3.0 T: 5.6/2.5, matrix size = 360 3 360, section thickness = 0.9 mm). Contrast material (0.2 mL/ kg body weight gadopentate dimeglumine [Magnevist; Schering, Berlin, Germany] or 0.1 mmol/kg gadoterate It is important to identify the subpopulations in which breast MR imaging may be most beneficial. A recent study (11) reported that surgeons often recommend breast MR imaging for patients at higher risk, of younger age, and with dense breasts and emphasized that potential selection bias by the surgeon's degree of subspecialization, as well as patient selection bias, influence the breast MR imaging outcome analysis. To obtain accurate outcome analysis of breast MR imaging in ILC, researchers should control for variables in patients who are referred for breast MR imaging and create a balanced cohort. Thus, in our study we investigated the association between preoperative breast MR imaging and surgical outcomes in patients with ILC by using propensity score matching to decide whether MR examination is beneficial in the ILC subtype of breast cancer.
Materials and Methods

Patients
This retrospective study was approved by the institutional review board. The requirement to obtain informed consent was waived. By using a computer search program at our institution, we identified 703 patients in whom ILC was newly diagnosed with biopsy or surgical excision between January 2005 and December 2016. We excluded 100 patients who were treated with neoadjuvant chemotherapy (n = 67), had initial stage IV disease (n = 8), were male patients (n = 2), had double primary cancers (n = 1), and had missing data on patient information or tumor characteristics (n = 22). We excluded patients with stage IV disease to limit the cohort to women in whom either breast-conserving surgery or mastectomy was likely to be considered. (1) . The incidence of ILC is increasing, especially in postmenopausal women (2) . Because of the infiltrative nature of ILC, it does not cause desmoplastic reaction and is difficult to diagnose clinically, with high false-negative rates (3, 4) . In addition, a clinical dilemma is that the less fibrotic reaction in ILC makes it difficult for pathologists and surgeons to determine the extent of the disease; thus, mastectomy is favored in ILC. ILC also has an increased propensity for multifocal and multicentric distribution and for bilaterality (20%-29%); thus, the rate of repeat surgery is high (3, (5) (6) (7) (8) .
Several studies (1,9,10) looked specifically at outcomes of magnetic resonance (MR) imaging in ILC in terms of the mastectomy rate and need for repeat surgery, and all but one of these studies (10) found that outcomes were improved with use of preoperative MR imaging. A retrospective study (9) found that preoperative MR imaging helped identify new ipsilateral (11%) and contralateral (7%) lesions and influenced surgical management in 23 of 92 patients (25%), and the change was believed to be justified in 20 (22%). Mann et al (1) have also shown in a retrospective cohort study that MR imaging reduces the repeat surgery rate (9%) after initial breast-conserving surgery; the rate was 27% in those who did not undergo preoperative MR imaging. There was also a trend toward a lower final mastectomy rate in the group that underwent MR imaging compared with the group that did not (48% vs 59%, respectively; P = .098). However, the study by Mann et al (1) was limited by a nonrandomized and retrospective design.
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Ha et al for potential confounders at a ratio of 1:1. Comparisons of matched data were performed by using the McNemar test or test of symmetry for categorical variables and the paired t test for continuous variables. Covariate imbalance was tested by using the standardized difference before and after matching. To find out if there is a subgroup of patients with ILC that would more likely benefit from preoperative MR imaging, we compared the group of patients that benefited from breast MR imaging with the group of patients with no change in surgical therapy or more extensive surgery than would otherwise be needed with respect to variables that were significant at univariate analysis of the MR imaging and non-MR imaging groups.
The primary end point of this study was comparison of the repeat surgery rates and initial and final mastectomy rates between the two groups (MR imaging and non-MR imaging groups). The Hosmer-Lemeshow goodness-offit statistic was used to evaluate the agreement between the two groups. To estimate the effect of breast MR imaging, we used generalized estimating equation methodology, and odds ratios with 95% confidence intervals were calculated to compare the likelihood of surgical outcomes with and without MR imaging. P , .05 was considered indicative of a statistically significant difference. Statistical analyses were performed with software (SPSS, version 23.0; Statistical Package for the Social Sciences, Chicago, Ill).
Results
Baseline Characteristics of Matched and Unmatched Patients
Of the 603 women, 369 (61.2%) underwent preoperative MR imaging and 234 (38.8%) did not. Before propensity score matching, patients who underwent preoperative MR imaging tended to be younger, be premenopausal, have dense breast tissue, have less family history of breast cancer, have lower histologic grade, and have more estrogen receptor and progesterone receptor positivity (Table 1) . After propensity breast MR imaging led to any changes in the surgical plan. In those patients whose surgical plans were changed because of MR imaging findings, we evaluated the final pathologic findings to assess whether the changes in surgical plans were justified. If the final pathologic finding corresponded with those from breast MR imaging (ie, confirmation of the new suspicious finding), the change in surgical management was deemed appropriate. We defined the unnecessarily extensive surgery rate as the percentage of patients who had more extensive surgery than would otherwise be needed owing to findings at supplementary breast MR imaging. All cases were reviewed by two breast radiologists (S.M.H., and E.Y.C., with 8 and 10 years of experience, respectively, in breast imaging), and the final decision was carried out by consensus when a discrepancy occurred.
Variable Selection for Propensity Score Matching Models
To compare surgical outcomes according to whether breast MR imaging was performed, we controlled for 17 covariates with regard to patient demographics, tumor characteristics, and various clinical features. These variables were as follows: age at the time of ILC diagnosis; menopausal status; marital status; childbirth; use of contraception; hormone-replacement therapy; history of breast cancer; family history of breast cancer; mammographic parenchymal density; pathologic staging based on the American Joint Committee on Cancer, seventh edition (12); histologic grade; lymph node positivity; lymphovascular invasion; hormonal receptor status, including estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2; and tumor size.
Statistical Analysis
We compared unmatched variables between the MR imaging and non-MR imaging groups by using the x 2 test or Student t test. Then, patients in each group were balanced with the propensity score matching method by using measured covariates to control meglumine [Dotarem; Guerbet, Villapinte, France]) was injected by using an MR imaging-compatible power injector (Spectris; Medrad, Pittsburgh, Pa) with a flow rate of 1 or 2 mL/sec followed by a 20-mL saline flush. Postprocessing manipulations included the production of standard subtraction, reverse subtraction, and maximum-intensity projection images.
Variable and Definitions
Surgical procedures for each patient were obtained from electronic medical records. We set three surgical outcomes: initial mastectomy rate, repeat surgery, and final mastectomy rate. We defined the initial surgical treatment episode as the time period beginning with the first diagnosis of breast malignancy with needle biopsy. The initial surgical treatment episode ended with the decision for definitive surgery as either breast-conserving surgery or mastectomy before a gap in surgery of more than 90 days. We defined initial mastectomy as mastectomy and not breast-conserving surgery performed during the initial surgical treatment episode beginning with the first diagnosis of breast cancer. Repeat surgery was defined as a claim for another breastconserving surgery or mastectomy after the day of the initial surgery but within the initial surgical treatment episode. The final surgery was defined as the last definitive surgery in the initial surgical treatment episode.
In the MR imaging group, we recorded whether any additional suspicious lesions were detected. An additional suspicious lesion was defined as a lesion occult or not suspicious at mammography and ultrasonography (US) and with similar morphologic and kinetic appearance as the index lesion or as a lesion highly suspicious for malignancy according to the Breast Imaging Reporting and Data System lexicon for breast MR imaging. All new MR imaging findings required pathologic proof of malignancy, usually by means of "second-look" US and biopsy, excision, or follow-up. MR imaging-guided biopsy was not performed in any patient. We also investigated whether preoperative BREAST IMAGING: Breast MR Imaging before Surgery Ha et al group (37.6%) underwent mastectomy as their initial surgery; the difference is not significant (P = .397) ( Note.-Except were indicated, data are numbers of patients, with percentages in parentheses. ER = estrogen receptor, HER2 = human epidermal growth factor receptor 2, LN = lymph node, PR = progesterone receptor.
* Data are means 6 standard deviations, with ranges in parentheses. † Statistically significant. staging in breast cancer, and even reducing the rate of repeat excision after breast-conserving surgery. Moreover, the final mastectomy rate was higher in patients who did not undergo preoperative breast MR imaging. However, the study by Mann et al (1) was limited by a nonrandomized and retrospective design. Another study in a subgroup analysis of patients with ILC and dense breasts (18) found a lower mastectomy rate in the MR imaging group (33.3% vs 42.6%; P = .003) but no reduction in the repeat surgery rate. On the contrary, in the study by Houssami et al (17) , MR imaging further increased the odds of mastectomy and reduced those of repeat surgery; however, this finding was not significant after an adjustment for age and suggested an unfavorable harm-to-benefit ratio for the routine use of MR imaging. In a populationbased study in which propensity score matching was used to examine breast MR imaging in elderly women and early stage invasive ductal carcinoma and ILC (20) , breast MR imaging was associated with an increased likelihood of an initial mastectomy for all patients and in all histologic subgroups. However, a of patients with ILC and evaluated for the effect of MR imaging by using propensity score matching. There has been effort with subgroup analysis to determine the benefit of preoperative breast MR imaging in patients with breast cancer. Some recommend performing breast MR imaging in a subgroup of patients who are premenopausal and diagnosed with ILC and high breast density because they would benefit most from MR imaging (13) . National and international guidelines, as well as the European Society of Breast Cancer Specialists, recommend preoperative MR imaging in patients with multifocal disease, lobular carcinoma subtype, high breast density, large ductal carcinoma in situ, and occult primary tumor (14) (15) (16) . Meanwhile, previous studies examining associations between MR imaging and surgical outcomes in patients with ILC have yielded conflicting results (1, (17) (18) (19) (20) . With respect to benefits, Mann et al (1) showed that preoperative MR imaging was beneficial in patients with ILC without increasing the rate of initial mastectomy, which is the most common objection to breast MR imaging imaging group (odds ratio: 0.876; 95% confidence interval: 0.580, 1.323; P = .528) ( Table 4) .
Repeat surgery.-Overall, 10 of the 369 patients in the MR imaging group (2.7%) underwent repeat surgery after breast-conserving surgery. In the non-MR imaging group, 44 of the 234 patients (18.8%) underwent repeat surgery (P , .001). After propensity score matching, the MR imaging group was also found to have significantly lower odds of undergoing repeat surgery compared with the non-MR imaging group (odds ratio: 0.140; 95% confidence interval: 0.058, 0.342; P , .001) (Figure) .
Final mastectomy.-In our study, 133 of the 369 patients in the MR imaging group (36.0%) had a lower frequency of final mastectomy as their only or final surgery, compared with 106 of the 234 patients in the non-MR imaging group (45.3%) (P = .029). After propensity score matching, the MR imaging group was not found to have increased odds of having a final mastectomy compared with the non-MR imaging group (odds ratio: 0.744; 95% confidence interval: 0.496, 1.114; P = .151).
Analysis of the Subgroup with Benefit (Appropriate Change) and No Benefit (No Change or More Extensive Surgery than Needed)
The subgroup analysis revealed no significant difference with respect to age at the time of diagnosis, menopausal status, family history of breast cancer, mammographic parenchymal density, histologic grade, and estrogen and progesterone receptor status (Table 5 ).
Discussion
The results of our study demonstrate that preoperative breast MR imaging in patients with ILC is associated with a reduction in the rate of repeat surgery without an increase in the initial or final mastectomy rates. We found that patients who underwent preoperative MR imaging had lower odds of having repeat surgery than did patients without-MR imaging. The main strength of our study is that we investigated the role of MR imaging in a relatively large group Note.-CI = confidence interval, OR = odds ratio.
* Statistically significant.
BREAST IMAGING: Breast MR Imaging before Surgery Ha et al for these additional findings. Extensive surgery should not be performed based solely on MR imaging appearance. Additional lesions detected with breast MR imaging raise the need for additional work-up and delayed treatment and result in more extensive surgery; therefore, preoperative MR imaging is still disputed (25) . However, an important point in favor of preoperative breast MR imaging is its ability to help detect additional occult lesions in contralateral breast tissue (15) . Its ability to depict otherwise occult contralateral lesions still could make it worthwhile in the preoperative workup, regardless of repeat surgery or mastectomy rates, depicting approximately 7%-10% of contralateral lesions in patients with ILC (23) and potentially improving patients' survival outcomes. This must be clarified in future studies. In our study, the contralateral malignancy rate was 3.8% (14 of 369 patients), which (89.4%) were found to be justified, with a benefit of 22.8% (84 of 369 patients), which is similar to the rate of 22% found by Heil et al (9) and with a more extensive surgery than needed rate of 2.7% (10 of 369 patients).
With regard to new suspicious findings at MR imaging, although the definitions may vary, Mann et al (23) observed additional lesions in approximately 32% of patients with ILC and pathologically proven malignancy in 88%. Contralateral disease was detected in 7% of the patients. In our study, MR imaging revealed additional suspicious lesions in 145 of 369 patients (39.3%). These lesions proved to be malignant in 95 of those 145 patients (65.5%), for a false-positive rate of 34.5% (50 of 145 patients). MR imaging may result in a higher false-positive rate and unnecessary biopsies owing to low specificity (24) . Therefore, preoperative biopsy should be performed reduced likelihood of a repeat surgery and equal likelihood of final mastectomy were observed in patients with ILC. The Comparative Effectiveness of MR Imaging in Breast Cancer, or COMICE, trial was one of the largest randomized controlled trials in the field, conducted in 1623 patients with breast cancer, of whom 816 were randomized to preoperative MR imaging with 6-month follow-up (19) . The COMICE trial suggests that patients with ILC were more likely to undergo repeat surgery (odds ratio, 0.52), but only a small number of patients with ILC was included (9%). Despite these conflicting opinions and the presence of unfavorable harm, the true effect of MR imaging in the ILC subgroup may have been underpowered in previous studies with the modest number of patients and heterogeneous breast cancer subtypes.
Preoperative breast MR imaging is known to change the therapeutic plan in approximately one-third of patients with ILC (21-23); in 15%-20%, the plan changes from breast-conserving surgery to mastectomy. Mann et al (23) reported a change in surgical therapy in approximately 28% of patients and an overtreatment rate of 2% based on MR imaging findings. Heil et al (9) reported 25% with a change in surgery and a 3% overtreatment rate. Similarly, in our study, 25.5% (94 of 369 patients) had a change in surgical therapy owing to MR imaging findings. In the 94 patients for whom the MR imaging findings changed the surgical management, 84 changes Odds ratios of surgical outcomes associated with preoperative breast MR imaging in the propensity score-matched cohort. Propensity score-matched odds ratio of patients with breast MR imaging compared with patients without MR imaging is represented by solid rectangle. Horizontal lines represent 95% confidence intervals. Note.-Except where indicated, data are numbers of patients, with percentages in parentheses. ER = estrogen receptor, PR = progesterone receptor.
* Data are means 6 standard deviations. Numbers in parentheses are the range.
is similar to reported incidence rates of 1.4%-6.2% (26) (27) (28) (29) . Our study has limitations. This was a retrospective study performed at a single institution; therefore, its results cannot be considered to be definitive evidence validating the use of preoperative breast MR imaging. Second, breast MR imaging protocols during the study period were nonuniform and have evolved; therefore, it was difficult to compare as a confounder in analysis. Third, we successfully balanced women with and without breast MR imaging on observed clinical, pathologic, and radiologic factors by using propensity score matching, but there may be unobserved characteristics that may be associated with clinical outcomes. Last, we did not assess local recurrence or survival.
In conclusion, our results show that preoperative breast MR imaging is beneficial in optimizing surgical planning in ILC, with detection of additional malignant foci and reduction of the chances of repeat surgery without increasing the rate of mastectomy. Our study provides evidence in support of the targeted use of preoperative breast MR imaging in patients with ILC. Future long-term follow-up is needed to determine the use of preoperative MR imaging in relation to patient outcome in terms of local recurrence and breast cancer-specific survival.
